291 related articles for article (PubMed ID: 10815806)
1. A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblasts.
Bossù P; Vanoni M; Wanke V; Cesaroni MP; Tropea F; Melillo G; Asti C; Porzio S; Ruggiero P; Di Cioccio V; Maurizi G; Ciabini A; Alberghina L
Oncogene; 2000 Apr; 19(17):2147-54. PubMed ID: 10815806
[TBL] [Abstract][Full Text] [Related]
2. The isolated catalytic hairpin of the Ras-specific guanine nucleotide exchange factor Cdc25Mm retains nucleotide dissociation activity but has impaired nucleotide exchange activity.
Sacco E; Fantinato S; Manzoni R; Metalli D; De Gioia L; Fantucci P; Alberghina L; Vanoni M
FEBS Lett; 2005 Dec; 579(30):6851-8. PubMed ID: 16325815
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the guanine nucleotide exchange reaction of Ras GTPase--evidence for a GTP/GDP displacement model.
Zhang B; Zhang Y; Shacter E; Zheng Y
Biochemistry; 2005 Feb; 44(7):2566-76. PubMed ID: 15709769
[TBL] [Abstract][Full Text] [Related]
4. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
[TBL] [Abstract][Full Text] [Related]
5. Acquired glucose sensitivity of k-ras transformed fibroblasts.
Chiaradonna F; Magnani C; Sacco E; Manzoni R; Alberghina L; Vanoni M
Biochem Soc Trans; 2005 Feb; 33(Pt 1):297-9. PubMed ID: 15667331
[TBL] [Abstract][Full Text] [Related]
6. Ras activation in response to phorbol ester proceeds independently of the EGFR via an unconventional nucleotide-exchange factor system in COS-7 cells.
Rubio I; Rennert K; Wittig U; Beer K; Dürst M; Stang SL; Stone J; Wetzker R
Biochem J; 2006 Sep; 398(2):243-56. PubMed ID: 16709153
[TBL] [Abstract][Full Text] [Related]
7. Identification of a dominant-negative mutation in the yeast CDC25 guanine nucleotide exchange factor for Ras.
Park W; Mosteller RD; Broek D
Oncogene; 1997 Feb; 14(7):831-6. PubMed ID: 9047390
[TBL] [Abstract][Full Text] [Related]
8. Guanine nucleotide exchange factors: activators of Ras superfamily proteins.
Overbeck AF; Brtva TR; Cox AD; Graham SM; Huff SY; Khosravi-Far R; Quilliam LA; Solski PA; Der CJ
Mol Reprod Dev; 1995 Dec; 42(4):468-76. PubMed ID: 8607978
[TBL] [Abstract][Full Text] [Related]
9. Characterization and properties of dominant-negative mutants of the ras-specific guanine nucleotide exchange factor CDC25(Mm).
Vanoni M; Bertini R; Sacco E; Fontanella L; Rieppi M; Colombo S; Martegani E; Carrera V; Moroni A; Bizzarri C; Sabbatini V; Cattozzo M; Colagrande A; Alberghina L
J Biol Chem; 1999 Dec; 274(51):36656-62. PubMed ID: 10593969
[TBL] [Abstract][Full Text] [Related]
10. R-Ras is regulated by activators and effectors distinct from those that control Ras function.
Huff SY; Quilliam LA; Cox AD; Der CJ
Oncogene; 1997 Jan; 14(2):133-43. PubMed ID: 9010215
[TBL] [Abstract][Full Text] [Related]
11. Ras-15A protein shares highly similar dominant-negative biological properties with Ras-17N and forms a stable, guanine-nucleotide resistant complex with CDC25 exchange factor.
Chen SY; Huff SY; Lai CC; Der CJ; Powers S
Oncogene; 1994 Sep; 9(9):2691-8. PubMed ID: 8058333
[TBL] [Abstract][Full Text] [Related]
12. The brain specific Ras exchange factor CDC25 Mm: modulation of its activity through Gi-protein-mediated signals.
Zippel R; Orecchia S; Sturani E; Martegani E
Oncogene; 1996 Jun; 12(12):2697-703. PubMed ID: 8700529
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of ras-dependent transformation by using dominant negative ras mutant N116Y].
Yokoyama T
Hokkaido Igaku Zasshi; 1995 May; 70(3):459-71. PubMed ID: 7590597
[TBL] [Abstract][Full Text] [Related]
14. R-Ras promotes tumor growth of cervical epithelial cells.
Rincón-Arano H; Rosales R; Mora N; Rodriguez-Castañeda A; Rosales C
Cancer; 2003 Feb; 97(3):575-85. PubMed ID: 12548599
[TBL] [Abstract][Full Text] [Related]
15. [RasGRP proteins--Ras-activating factors].
Szamałek M; Baer-Dubowska W
Postepy Biochem; 2007; 53(2):112-20. PubMed ID: 17969871
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis by fluorescence of the interaction between Ras and the catalytic domain of the guanine nucleotide exchange factor Cdc25Mm.
Lenzen C; Cool RH; Prinz H; Kuhlmann J; Wittinghofer A
Biochemistry; 1998 May; 37(20):7420-30. PubMed ID: 9585556
[TBL] [Abstract][Full Text] [Related]
17. Cellular ras gene activity is required for full neoplastic transformation by the large tumor antigen of SV40.
Raptis L; Brownell HL; Corbley MJ; Wood KW; Wang D; Haliotis T
Cell Growth Differ; 1997 Aug; 8(8):891-901. PubMed ID: 9269898
[TBL] [Abstract][Full Text] [Related]
18. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
19. Novel RasGRF1-derived Tat-fused peptides inhibiting Ras-dependent proliferation and migration in mouse and human cancer cells.
Sacco E; Metalli D; Spinelli M; Manzoni R; Samalikova M; Grandori R; Morrione A; Traversa S; Alberghina L; Vanoni M
Biotechnol Adv; 2012; 30(1):233-43. PubMed ID: 21620943
[TBL] [Abstract][Full Text] [Related]
20. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
